AbbVie Inc.AbbVie Inc.AbbVie Inc.

AbbVie Inc.

Nessun attività

Corporate debt securities

Below is the list of AbbVie Inc. bonds, sorted by yield to maturity. Investors often opt for a company's bonds for their increased stability in times of market volatility. Study prices, yields, and other stats and find a reliable investment.
Simbolo
YTM %
Volume
Prezzo %
Cedola %
Data di maturazione
Importo in eccesso
Valore nominale
Importo min. denominazione
Emittente
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
7,00%26 K76,04%4,750%2045-03-1553,51 M USD1.000,00 USD2.000,00 USD
Allergan Funding SCS
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
6,40%12 K83,25%4,850%2044-06-1565,23 M USD1.000,00 USD2.000,00 USD
Allergan Funding SCS
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
6,38%124 K81,98%4,625%2042-10-0167,49 M USD1.000,00 USD2.000,00 USD
Actavis, Inc.
XS190919331Allergan Funding SCS 2.625% 15-NOV-2028
6,31%090,50%2,625%2028-11-1572,11 M EUR1.000,00 EUR100.000,00 EUR
Allergan Funding SCS
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
5,82%480 K90,97%4,550%2035-03-15107,65 M USD1.000,00 USD2.000,00 USD
Allergan Funding SCS
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
5,64%2,93 M97,81%5,500%2064-03-151,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
5,56%730 K97,74%5,400%2054-03-153 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
5,55%119 K82,82%4,250%2049-11-215,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAW9AbbVie Inc. 4.45% 14-MAY-2046
5,54%086,71%4,450%2046-05-142 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV6009613AbbVie Inc. 5.6% 15-MAR-2055
5,54%396 K100,83%5,600%2055-03-15750 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABBAbbVie Inc. 4.7% 14-MAY-2045
5,53%090,18%4,700%2045-05-142,7 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
5,53%104 K91,54%4,875%2048-11-141,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
5,50%545 K91,24%4,750%2045-03-15827,09 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
5,49%26 K90,47%3,200%2029-11-2162,52 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
5,46%30 K92,96%4,850%2044-06-151,01 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
5,44%54 K91,09%4,625%2042-10-01389,22 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
5,41%100 K99,29%5,350%2044-03-15750 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US00287YAM12AbbVie Inc. 4.4% 06-NOV-2042
5,37%089,29%4,400%2042-11-062,6 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
5,13%1,93 M89,27%4,050%2039-11-214 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAV1AbbVie Inc. 4.3% 14-MAY-2036
4,83%095,70%4,300%2036-05-141 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAR0AbbVie Inc. 4.5% 14-MAY-2035
4,77%097,99%4,500%2035-05-142,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
4,73%170 K98,64%4,550%2035-03-151,68 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV6009165AbbVie Inc. 5.2% 15-MAR-2035
4,71%660 K103,65%5,200%2035-03-151 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
4,68%6,31 M102,85%5,050%2034-03-153 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV6009612AbbVie Inc. 4.875% 15-MAR-2030
4,27%5,95 M103,14%4,875%2030-03-151 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
4,23%1,83 M103,34%4,950%2031-03-152 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
4,08%1,92 M96,85%3,200%2029-11-215,44 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
US287YAY5AbbVie Inc. 3.2% 14-MAY-2026
4,06%099,68%3,200%2026-05-142 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
3,98%3,21 M102,45%4,800%2029-03-152,5 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
3,94%4,71 M101,03%4,800%2027-03-152,25 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
3,91%10,74 M99,15%2,950%2026-11-213,99 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
3,90%3,05 M100,93%4,250%2028-11-141,75 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV6009611AbbVie Inc. 4.65% 15-MAR-2028
3,90%1,26 M101,59%4,650%2028-03-151,25 B USD1.000,00 USD2.000,00 USDAbbVie, Inc.
XXS162262122Allergan Funding SCS 2.125% 01-JUN-2029
3,87%094,47%2,125%2029-06-0136,46 M EUR1.000,00 EUR100.000,00 EUR
Allergan Funding SCS
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
3,16%0126,76%4,750%2045-03-155 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABGAbbVie Inc. 1.25% 18-NOV-2031
3,14%089,94%1,250%2031-11-18650 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
3,13%0128,71%4,850%2044-06-15100 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
3,13%0121,31%4,250%2049-11-214,95 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
XS212591491AbbVie Inc. 2.125% 01-JUN-2029
2,80%097,81%2,125%2029-06-01506,09 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
XS152090781AbbVie Inc. 2.125% 17-NOV-2028
2,70%098,42%2,125%2028-11-17750 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
XS212591483AbbVie Inc. 2.625% 15-NOV-2028
2,68%099,86%2,625%2028-11-15427,79 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2,57%0123,74%4,550%2035-03-151 K USD1.000,00 USD2.000,00 USDAbbVie, Inc.
4ABEAbbVie Inc. 0.75% 18-NOV-2027
2,45%096,87%0,750%2027-11-18750 M EUR1.000,00 EUR100.000,00 EURAbbVie, Inc.
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
−5,92%098,80%2,950%2026-11-219,24 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
4,400%2042-11-061,1 M USD1.000,00 USD2.000,00 USDAbbVie, Inc.